Jaka jest cena za Pascal Biosciences Inc. (PSCBF)

Cena za Pascal Biosciences Inc. (PSCBF) wynosi $0.1

Jaka jest kapitalizacja rynkowa dla Pascal Biosciences Inc. (PSCBF)

Kapitalizacja rynkowa dla Pascal Biosciences Inc. (PSCBF) wynosi $1.31M

Pascal Biosciences Inc. (PSCBF) Wskaźnik C/WK

Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.

Rok	Wskaźnik P/B	Zmień
2026 (TTM)	2.64	127.72%
2023	1.16	-181.08%
2022	-1.43	7,479.37%
2021	-0.02	6,200.00%
2020	0.00	0.00%
2019	0.00	0.00%

Rok

Wskaźnik P/B

Zmień

2026 (TTM)

2.64

127.72%

2023

1.16

-181.08%

2022

-1.43

7,479.37%

2021

-0.02

6,200.00%

2020

0.00

0.00%

2019

0.00

0.00%

Firma	Wskaźnik P/B	Różnica wskaźnika P/B	Kraj
Vertex Pharmaceuticals Incorporated VRTX.US	6.2613	137.04%	US
Argenx SE ARGX.US	6.3483	140.33%	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	3.634	37.57%	BE

Firma

Wskaźnik P/B

Różnica wskaźnika P/B

Kraj